Trials / Completed
CompletedNCT03808285
Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to adescription of mandibular osteomylitis in patients having had a treatment by DENOSUMAB. Indeed, one of the adverse effect ot this molecule is to induce mandibular infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mandibular osteomylitis |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2019-01-17
- Last updated
- 2019-02-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03808285. Inclusion in this directory is not an endorsement.